FLUOROETHOXYBENZOVESAMICOL F-18 for down syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Aug 2021: Trial started, NCT05231798
  2. 9 Feb 2022: Trial registered, NCT05231798

The trials

NCT05231798: Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

State
Under way
Phase
Phase 2
People
30 planned
Started
19 Aug 2021
Primary completion
30 Apr 2027
Arms
Down Syndrome
Results
None posted
  1. 19 Aug 2021: Trial started
  2. 9 Feb 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as [18F]-FEOBV Radiotracer.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.